What are the three types of HIV tests available to patients, how do they differ, and how can patients determine the best ...
People with MS have persistently high levels of EBV antibodies, a study found, pointing to a way to distinguish MS from ...
Chronic hepatitis D coinfection affects an estimated 12 million people globally, with higher prevalence in low-income and middle-income countries, especially the African and Western Pacific regions.
The FDA’s recent announcement to reduce, and in some cases replace, animal testing for monoclonal antibodies and other therapeutics represents one of the most consequential regulatory developments in ...
Almost all AAV cases were diagnosed in individuals with high pretest probability, including those with renal disease, peripheral neuropathies, or pulmonary infiltrates.
Federal regulators in the United States are pushing harder than ever to reduce and eventually replace animal testing in drug ...
The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t mean animal testing in the US is over.
There are no new cases of foot-and-mouth disease, while culling and sampling are continuing without obstruction, veterinary services spokeswoman Sotiria Georgiadou said.Georgiadou said the second ...
The U.S. Food and Drug Administration is actively steering drug developers away from traditional animal studies and toward human-biology-based testing methods for monoclonal antibody programs. The ...
University of Missouri researchers develop live HPAI vaccine with DIVA technology to distinguish vaccinated from infected birds, solving major poultry export barriers and reducing costs significantly.
Creative Biolabs today announced the upgrade of its next-generation drug discovery pipeline with integrated AI-driven ...
Officials with the FDA have released a draft guidance that aims to help drug developers validate new approach methodologies (NAMs) that can be used in place of animal testing. Based on human-centric ...